Nephros (NEPH) Enterprise Value (2016 - 2025)
Historic Enterprise Value for Nephros (NEPH) over the last 17 years, with Q3 2025 value amounting to -$5.2 million.
- Nephros' Enterprise Value fell 11045.99% to -$5.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$5.2 million, marking a year-over-year decrease of 11045.99%. This contributed to the annual value of -$3.8 million for FY2024, which is 1270.03% up from last year.
- As of Q3 2025, Nephros' Enterprise Value stood at -$5.2 million, which was down 11045.99% from -$5.1 million recorded in Q2 2025.
- Nephros' 5-year Enterprise Value high stood at -$345000.0 for Q4 2022, and its period low was -$5.2 million during Q2 2021.
- Over the past 5 years, Nephros' median Enterprise Value value was -$3.9 million (recorded in 2021), while the average stood at -$3.5 million.
- As far as peak fluctuations go, Nephros' Enterprise Value soared by 9119.67% in 2022, and later plummeted by 114840.58% in 2023.
- Over the past 5 years, Nephros' Enterprise Value (Quarter) stood at -$3.9 million in 2021, then soared by 91.2% to -$345000.0 in 2022, then tumbled by 1148.41% to -$4.3 million in 2023, then rose by 12.7% to -$3.8 million in 2024, then crashed by 37.53% to -$5.2 million in 2025.
- Its Enterprise Value stands at -$5.2 million for Q3 2025, versus -$5.1 million for Q2 2025 and -$4.1 million for Q1 2025.